DSS, Inc. (DSS) AI Stock Analysis

DSS, Inc., based in West Henrietta, New York, operates across diverse sectors including product packaging, biotechnology, direct commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy. It manufactures packaging solutions such as custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions, while distributing nutritional and personal care products. The company also invests in biohealth and biomedical businesses working on treatments for neurological, oncological, and immune-related diseases, as well as open-air airborne disease defense. Furthermore, DSS acquires equity positions in commercial banks and financial entities, manages a healthcare real estate investment trust, and develops sustainable energy solutions.

Between FY2021 and FY2025, DSS grew revenue at a 5-year CAGR of 6.2%, rising from $20.3M in FY2021 to a peak of $28.4M in FY2022 before declining to $19.1M in FY2024 and rebounding 8.7% to $20.8M in FY2025. However, profitability remained negative across this span. Operating margin was -116.0% in FY2021 and -69.5% in FY2025, while net margin went from -163.3% to -115.3%. In FY2025, net income was -$23.9M, representing an EPS of -$2.67. For the trailing twelve months ending June 30, 2026, revenue stood at $18.5M, with quarterly revenue falling 31.8% year-over-year in the latest quarter and operating margin at -105.0%.

As of June 30, 2026, DSS held $5.2M in cash and short-term investments alongside total debt of $43.1M, creating a net debt position of $38.0M. The company reported negative shareholders' equity of -$382,000 against total assets of $68.4M, with a current ratio of 0.19. Operating cash flow in FY2025 was -$9.1M, and free cash flow stood at -$9.4M. Capital expenditures reached $306,000 in FY2025, while the company's share count declined 85.9% over a 5-year period.

With a market capitalization of $6.1M and an enterprise value of $45.0M, DSS trades at a price-to-sales multiple of 0.4x, lower than the 0.7x median of its US-listed Consumer Cyclical peers. Its enterprise value-to-revenue multiple stands at 2.4x, and its price-to-book multiple is 1.7x. The company does not have positive earnings multiples, whereas the peer median trailing P/E is 18.0x. Over the past year, DSS shares fell 54.8%, trailing the S&P 500 (SPY) return of 16.8%. Over five years, the stock dropped 97.1%, while the S&P 500 gained 83.0%.

Wall Street coverage for DSS includes 1 Strong Buy rating, 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $3.00, representing a 391.8% premium over the October 16, 2026 closing price of $0.61. For the fiscal year ending December 31, 2026, the consensus EPS estimate is -$1.38, indicating projected EPS growth of 48.1%, with estimated revenue of $19.5M. The company has beaten EPS estimates in 1 of the last 4 quarters, and its next earnings date is November 13, 2026.

This page is an AI-written research summary of DSS, Inc. (DSS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: DSS income statement, DSS balance sheet, DSS key metrics, DSS analyst forecast, DSS chart. See the DSS stock overview for the latest quote and news.